Syndax Pharmaceuticals Inc
SNDX
Market Cap$920.71M
Close$
$-2.02
118.8% downside
Current Fair Value
118.8% downsideOvervalued by 118.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $920.71 Million |
|---|---|
| Enterprise Value | $766.72 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-3.73 |
| Beta | 0.82 |
| Outstanding Shares | 85,622,065 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -2.76 |
|---|---|
| PEG | -4.28 |
| Price to Sales | - |
| Price to Book Ratio | 3.57 |
| Enterprise Value to Revenue | 46.37 |
| Enterprise Value to EBIT | -2.43 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Syndax Pharmaceuticals Inc
CEO: Arlene Morris